News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
97,078 Results
Type
Article (8517)
Company Profile (52)
Press Release (88509)
Multimedia
Podcasts (11)
Webinars (1)
Section
Business (22620)
Career Advice (109)
Deals (3385)
Drug Delivery (7)
Drug Development (23197)
Employer Resources (13)
FDA (2367)
Job Trends (2554)
News (48913)
Policy (4388)
Tag
2027 Biotech Bay Standard (2)
Academia (661)
Accelerated approval (10)
Adcomms (6)
Allergies (61)
Alliances (7178)
ALS (21)
Alzheimer's disease (281)
Antibody-drug conjugate (ADC) (75)
Approvals (2459)
Artificial intelligence (88)
Autoimmune disease (116)
Automation (6)
Bankruptcy (19)
Best Places to Work (2481)
Biosimilars (34)
Biotechnology (46)
Bladder cancer (78)
Brain cancer (23)
Breast cancer (176)
Cancer (2013)
Cardiovascular disease (23)
Career advice (84)
CAR-T (170)
CDC (43)
Cell therapy (372)
Cervical cancer (11)
Clinical research (19232)
Collaboration (383)
Compensation (111)
Complete response letters (11)
COVID-19 (1533)
CRISPR (23)
C-suite (148)
Cystic fibrosis (16)
Data (2158)
Denatured (2)
Depression (4)
Diabetes (92)
Diagnostics (667)
Digital health (1)
Diversity (2)
Diversity, equity & inclusion (4)
Drug discovery (42)
Drug pricing (7)
Drug shortages (1)
Duchenne muscular dystrophy (32)
Earnings (8643)
Editorial (11)
Employer branding (1)
Employer resources (11)
Events (16881)
Executive appointments (143)
FDA (3067)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (8)
Funding (308)
Gene editing (39)
Generative AI (8)
Gene therapy (122)
GLP-1 (100)
Government (1106)
Grass and pollen (2)
Guidances (60)
Healthcare (3089)
HIV (24)
Huntington's disease (2)
IgA nephropathy (43)
Immunology and inflammation (153)
Immuno-oncology (40)
Indications (32)
Infectious disease (1701)
Inflammatory bowel disease (102)
Influenza (75)
Intellectual property (51)
Interviews (22)
IPO (2026)
IRA (4)
Job creations (240)
Job search strategy (79)
JPM (4)
Kidney cancer (5)
Labor market (4)
Layoffs (66)
Legal (319)
Liver cancer (31)
Longevity (1)
Lung cancer (301)
Lymphoma (210)
Machine learning (10)
Management (4)
Manufacturing (128)
MASH (14)
Medical device (426)
Medtech (428)
Mergers & acquisitions (1546)
Metabolic disorders (163)
Multiple sclerosis (93)
Neurodegenerative disease (52)
Neuropsychiatric disorders (5)
Neuroscience (479)
NextGen: Class of 2026 (802)
Non-profit (438)
Now hiring (1)
Obesity (47)
Opinion (34)
Ovarian cancer (87)
Pain (18)
Pancreatic cancer (104)
Parkinson's disease (37)
Partnered (2)
Patents (106)
Patient recruitment (113)
Peanut (38)
People (6888)
Pharmaceutical (7)
Pharmacy benefit managers (3)
Phase 1 (7557)
Phase 2 (8717)
Phase 3 (5593)
Pipeline (1402)
Policy (56)
Postmarket research (379)
Preclinical (3114)
Press Release (16)
Prostate cancer (59)
Psychedelics (4)
Radiopharmaceuticals (34)
Rare diseases (149)
Real estate (370)
Recruiting (5)
Regulatory (4078)
Reports (7)
Research institute (735)
Resumes & cover letters (20)
Rett syndrome (3)
RNA editing (1)
RSV (66)
Schizophrenia (5)
Series A (47)
Series B (42)
Sickle cell disease (16)
Spinal muscular atrophy (5)
Sponsored (6)
Startups (569)
State (1)
Stomach cancer (10)
Supply chain (13)
Tariffs (7)
The Weekly (9)
Vaccines (757)
Venture capital (9)
Weight loss (22)
Women's health (3)
Date
Today (23)
Last 7 days (109)
Last 30 days (394)
Last 365 days (6689)
2026 (656)
2025 (6778)
2024 (7440)
2023 (8370)
2022 (10319)
2021 (11607)
2020 (9953)
2019 (5922)
2018 (4477)
2017 (4797)
2016 (4087)
2015 (4588)
2014 (2821)
2013 (1966)
2012 (1872)
2011 (1832)
2010 (1572)
Location
Africa (93)
Alabama (14)
Arizona (15)
Asia (6937)
Australia (1245)
California (2462)
Canada (509)
China (305)
Colorado (94)
Connecticut (80)
Delaware (97)
Europe (15137)
Florida (327)
Georgia (63)
Hawaii (2)
Idaho (15)
Illinois (158)
India (7)
Indiana (175)
Iowa (11)
Japan (72)
Kansas (4)
Kentucky (4)
Maine (50)
Maryland (307)
Massachusetts (1877)
Michigan (17)
Minnesota (21)
Missouri (15)
Montana (10)
Nebraska (2)
Nevada (24)
New Hampshire (1)
New Jersey (738)
New Mexico (4)
New York (772)
North Carolina (138)
North Dakota (1)
Northern California (1256)
Ohio (32)
Oklahoma (3)
Oregon (6)
Pennsylvania (441)
Puerto Rico (2)
Rhode Island (18)
South America (90)
South Carolina (2)
Southern California (903)
Tennessee (5)
Texas (436)
United States (8494)
Utah (30)
Virginia (62)
Washington D.C. (6)
Washington State (315)
Wisconsin (10)
97,078 Results for "immuneering".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Parkinson’s disease
AC Immune’s Parkinson’s Immunotherapy Appears to Slow Disease Progression
In a first for the Parkinson’s field, AC Immune’s immunotherapy has stabilized key biomarkers that suggest an effect on the disease’s course.
December 11, 2025
·
1 min read
·
Annalee Armstrong
Layoffs
AC Immune Downsizes by 30%, Narrows Pipeline Focus
The reprioritization effort will help AC Immune extend its cash runway through the third quarter of 2027.
September 4, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Immuneering to be Added to the Nasdaq Biotechnology Index (NBI)
December 17, 2025
·
1 min read
Press Releases
Molecule Found to Drive Skin Cancer Growth and Evade Immune Detection
February 11, 2026
·
5 min read
Pancreatic cancer
Immuneering Asset Nearly Doubles Overall Survival in Pancreatic Cancer After 9 Months
Truist analysts called the results “encouraging” while pointing out certain unknowns in the data. Immuneering plans to kick off a registrational trial for atebimetinib later this year.
September 25, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Immunic Highlights 2025 Accomplishments and Upcoming Milestones
January 7, 2026
·
12 min read
Press Releases
Parse Biosciences Launches Workflow for Immune Repertoire and Transcriptome Analysis
January 23, 2026
·
2 min read
Press Releases
BriaCell Patients’ Images Show Regression and Resolution of Metastasized Tumors and Immune Activation
January 29, 2026
·
6 min read
Press Releases
Is Vaccination and New Drugs Really the Answer to Immune Health for Modern People?- Commentary by Unexakorea
January 29, 2026
·
1 min read
Press Releases
Flagship Pioneering and Repertoire® Immune Medicines Announce Agreement to Identify T Cell-Targeted Immune Medicines for Prostate Cancer Under Strategic Partnership with Pfizer
December 23, 2025
·
4 min read
1 of 9,708
Next
